ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Advisor, Process Development Engineer, RNA/LNP at Eli Lilly and Company - ApplyBlast

Senior Advisor, Process Development Engineer, RNA/LNP

Eli Lilly and Company

9 months ago

4.0 on Glassdoor

United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

A process development engineer position within Eli Lilly’s Bioproduct Research & Development organization focused on advancing genetic medicine programs from clinical development toward commercialization. The role centers on developing nonviral delivery vehicles such as RNA-lipid nanoparticles and supporting integration across Lilly sites. The position is based at Lilly’s Indianapolis tech center and involves collaboration with internal and external manufacturing partners.

Skills

Qualifications

Ph.D. in Chemical Engineering, Biomedical Engineering, Chemistry, or Pharmaceutical SciencesMS in Chemical Engineering, Biomedical Engineering, Chemistry, or Pharmaceutical Sciences

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.